Survival difference between mucinous vs. non-mucinous colorectal cancer following cytoreductive surgery and intraperitoneal chemotherapy

References

• Park JS, Huh JW, Park YA, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer. Medicine. 2015;94:e658.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Michalopoulos A, Netta S, et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol. 2004;8:s123–s125.
   PubMedGoogle Scholar
• Smeenk R, Verwaal V, Zoetmulder F. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408–1414.
   PubMed Web of Science ®Google Scholar
• Chua TC, Yan TD, Saxena A, et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality. Ann Surg. 2009;249:900–907.
   PubMed Web of Science ®Google Scholar
• Elias D, Gilly F, Boutitie F, et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63–68.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737–3743.
   PubMed Web of Science ®Google Scholar
• Debunne H, Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects. Acta Chir Belg. 2013;113:385–390.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.
   PubMed Web of Science ®Google Scholar
• Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Peritoneal carcinomatosis: principles of management. Boston, MA: Springer; 1996. 359–374.
   Google Scholar
• Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205.
   PubMed Web of Science ®Google Scholar
• Huang Y, Alzahrani NA, Liauw W, et al. Early postoperative intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasms with Pseudomyxoma peritonei: is it beneficial?. Ann Surg Oncol. 2017;24:176–183.
   PubMed Web of Science ®Google Scholar
• Coindre J, Trojani M, Maree D, et al. The prognostic significance of specific histologic features of carcinoma of the colon and rectum. Surg Gynecol Obstet. 1981;153:511–514.
   PubMedGoogle Scholar
• Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891–1900.
   PubMed Web of Science ®Google Scholar
• Green JB, Timmcke AE, Mitchell WT, et al. Mucinous carcinoma-just another colon cancer? Dis Colon Rectum. 1993;36:49–54.
   PubMed Web of Science ®Google Scholar
• Bagante F, Spolverato G, Beal E, et al. Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer. J Surg Oncol. 2018;117:1355–1363.
   PubMed Web of Science ®Google Scholar
• Coco C, Magistrelli P, Vecchio F, et al. The prognostic role of anatomo-pathological factors in colorectal cancer: an univariate analysis. Ann Ital Chir. 1991;62:355–362.
   PubMedGoogle Scholar
• Langner C, Harbaum L, Pollheimer MJ, et al. Mucinous differentiation in colorectal cancer–indicator of poor prognosis? Histopathology. 2012;60:1060–1072.
   PubMed Web of Science ®Google Scholar
• Verhulst J, Ferdinande L, Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis. J Clin Pathol. 2012;65:381–388.
   PubMed Web of Science ®Google Scholar
• Yu D, Gao P, Song Y, et al. The differences on efficacy of oxaliplatin in locally advanced colon cancer between mucinous and nonmucinous adenocarcinoma. Cancer Med. 2018;7:600–615.
   PubMed Web of Science ®Google Scholar
• Numata M, Shiozawa M, Watanabe T, et al. The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease. World J Surg Oncol. 2012;10:109.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Mochizuki H, Hase K, et al. Assessment of clinicopathologic features of colorectal mucinous adenocarcinoma. Am J Surg. 1993;166:257–261.
   PubMed Web of Science ®Google Scholar
• Glasgow S, Yu J, Carvalho L, et al. Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. Br J Cancer. 2005;92:259.
   PubMed Web of Science ®Google Scholar
• Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006;19:59.
   PubMed Web of Science ®Google Scholar
• Hugen N, Verhoeven R, Radema S, et al. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma. Ann Oncol. 2013;24:2819–2824.
   PubMed Web of Science ®Google Scholar
• Kermanshahi TR, Magge D, Choudry H, et al. Mucinous and signet ring cell differentiation affect patterns of metastasis in colorectal carcinoma and influence survival. Int J Surg Pathol. 2017;25:108–117.
   PubMed Web of Science ®Google Scholar
• Ubink I, van Eden W, Snaebjornsson P, et al. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases. Br J Surg. 2018;105:e204.
   PubMed Web of Science ®Google Scholar
• Jass J. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–130.
   PubMed Web of Science ®Google Scholar